LSU Health Shreveport has established the Emerging Viral Threat (EVT) Laboratory to address the need for faster detection and processing of COVID-19 tests.
LSU Health Shreveport is Comprised of Three Professional Schools.
Exceeding the national NRMP Main Residency Match® rate by 18.7% with 98.3% of MS4 matching
Global health opportunities
Enrollment of 542 Students
- 100% Licensure Exam Pass Rates across all 7 programs
- Early clinical integration
- Enrollment of 326 Students
Our Mission is to
TEACH - HEAL - DISCOVER
We are educating and training the next generation of health care professionals and scientists who will continue our proud legacy of innovative and lifesaving healthcare and cutting-edge medical research. As one of only one hundred forty academic medical centers (AMC) in the nation, LSU Health Shreveport is a revered treasure in a community that fought decades for its creation. Learn more about our Student Achievement.
Shreveport-Bossier has so much to offer that you have to experience it. In partnership with our local S-B Convention & Tourist Bureau, we have some videos to share that only begin to tell the story of all there is to see and do in Northwest Louisiana. We hope you will choose LSU Health Shreveport as your place for learning, working and living!
"I wish the very best to our students staying in Shreveport, as well as to those who matched in programs around the country. I am confident each one of them will represent LSU Health Shreveport well and strengthen our legacy of successful medical education,” said LSU Health Shreveport Chancellor Dr. G.E. Ghali.
LSUHS leadership, faculty, staff, students and community supporters recently honored the continued growth of research initiatives and funding at the second annual Research Celebration event held on February 25, 2020.
Cherie-Ann O. Nathan, MD is the lead author of a study that found a targeted therapy drug used for breast and kidney cancers may also extend survival for patients with advanced head and neck cancer.
The symposium presented a multidisciplinary approach for the care and treatment of patients with neurological spinal deformities, educating healthcare providers about best current practices and future treatment directions
Internationally recognized for his research on inflammatory vascular pathology, specifically on and the relationship between inflammation and vascular growth and function, Dr. Kevil discovered detailed mechanistic relationships between angiogenesis and inflammation.
Marlene Broussard, MD, MBA, Associate Professor and Interim Chairman of the Department of Pediatrics at LSU Health Shreveport, is one of the country’s first board certified Pediatric Hospital Medicine Specialists.
Three Fellows in the Department of Pathology and the Center for Cardiovascular Diseases and Sciences have been awarded Fellowships funding their ongoing research into cardiovascular diseases.
Dr. Stephan N. Witt, Chairman of the Department of Biochemistry, was recently named a Senior Fellow of the Cell Stress Society International (CSSI).
Aphios Granted U.S. Patent for Oral Administration of Bryostatin-1 Nanoparticles for Treatment of Neurodegenerative Diseases, which was co-invented by LSU Health Shreveport professor, Dr. J. Steven Alexander.